Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global RNA-Based Therapeutics and Vaccines Market Size Growth Rate by Type (2013-2025) 1.4.2 RNA-Based Therapeutics 1.4.3 RNA-Based Vaccines 1.5 Market by Application 1.5.1 Global RNA-Based Therapeutics and Vaccines Market Share by Application (2013-2025) 1.5.2 Oncology 1.5.3 Immunology 1.5.4 Ophthalmology 1.5.5 Cardiovascular Diseases 1.5.6 Infectious Diseases 1.5.7 Genetic Diseases 1.5.8 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 RNA-Based Therapeutics and Vaccines Market Size 2.2 RNA-Based Therapeutics and Vaccines Growth Trends by Regions 2.2.1 RNA-Based Therapeutics and Vaccines Market Size by Regions (2013-2025) 2.2.2 RNA-Based Therapeutics and Vaccines Market Share by Regions (2013-2018) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 RNA-Based Therapeutics and Vaccines Market Size by Manufacturers 3.1.1 Global RNA-Based Therapeutics and Vaccines Revenue by Manufacturers (2013-2018) 3.1.2 Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Manufacturers (2013-2018) 3.1.3 Global RNA-Based Therapeutics and Vaccines Market Concentration Ratio (CR5 and HHI) 3.2 RNA-Based Therapeutics and Vaccines Key Players Head office and Area Served 3.3 Key Players RNA-Based Therapeutics and Vaccines Product/Solution/Service 3.4 Date of Enter into RNA-Based Therapeutics and Vaccines Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global RNA-Based Therapeutics and Vaccines Market Size by Type (2013-2018) 4.2 Global RNA-Based Therapeutics and Vaccines Market Size by Application (2013-2018) 5 United States 5.1 United States RNA-Based Therapeutics and Vaccines Market Size (2013-2018) 5.2 RNA-Based Therapeutics and Vaccines Key Players in United States 5.3 United States RNA-Based Therapeutics and Vaccines Market Size by Type 5.4 United States RNA-Based Therapeutics and Vaccines Market Size by Application 6 Europe 6.1 Europe RNA-Based Therapeutics and Vaccines Market Size (2013-2018) 6.2 RNA-Based Therapeutics and Vaccines Key Players in Europe 6.3 Europe RNA-Based Therapeutics and Vaccines Market Size by Type 6.4 Europe RNA-Based Therapeutics and Vaccines Market Size by Application 7 China 7.1 China RNA-Based Therapeutics and Vaccines Market Size (2013-2018) 7.2 RNA-Based Therapeutics and Vaccines Key Players in China 7.3 China RNA-Based Therapeutics and Vaccines Market Size by Type 7.4 China RNA-Based Therapeutics and Vaccines Market Size by Application 8 Japan 8.1 Japan RNA-Based Therapeutics and Vaccines Market Size (2013-2018) 8.2 RNA-Based Therapeutics and Vaccines Key Players in Japan 8.3 Japan RNA-Based Therapeutics and Vaccines Market Size by Type 8.4 Japan RNA-Based Therapeutics and Vaccines Market Size by Application 9 Southeast Asia 9.1 Southeast Asia RNA-Based Therapeutics and Vaccines Market Size (2013-2018) 9.2 RNA-Based Therapeutics and Vaccines Key Players in Southeast Asia 9.3 Southeast Asia RNA-Based Therapeutics and Vaccines Market Size by Type 9.4 Southeast Asia RNA-Based Therapeutics and Vaccines Market Size by Application 10 India 10.1 India RNA-Based Therapeutics and Vaccines Market Size (2013-2018) 10.2 RNA-Based Therapeutics and Vaccines Key Players in India 10.3 India RNA-Based Therapeutics and Vaccines Market Size by Type 10.4 India RNA-Based Therapeutics and Vaccines Market Size by Application 11 Central & South America 11.1 Central & South America RNA-Based Therapeutics and Vaccines Market Size (2013-2018) 11.2 RNA-Based Therapeutics and Vaccines Key Players in Central & South America 11.3 Central & South America RNA-Based Therapeutics and Vaccines Market Size by Type 11.4 Central & South America RNA-Based Therapeutics and Vaccines Market Size by Application 12 International Players Profiles 12.1 Alnylam Pharmaceuticals 12.1.1 Alnylam Pharmaceuticals Company Details 12.1.2 Company Description and Business Overview 12.1.3 RNA-Based Therapeutics and Vaccines Introduction 12.1.4 Alnylam Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2013-2018) 12.1.5 Alnylam Pharmaceuticals Recent Development 12.2 Arbutus Biopharma 12.2.1 Arbutus Biopharma Company Details 12.2.2 Company Description and Business Overview 12.2.3 RNA-Based Therapeutics and Vaccines Introduction 12.2.4 Arbutus Biopharma Revenue in RNA-Based Therapeutics and Vaccines Business (2013-2018) 12.2.5 Arbutus Biopharma Recent Development 12.3 Arrowhead Pharmaceuticals 12.3.1 Arrowhead Pharmaceuticals Company Details 12.3.2 Company Description and Business Overview 12.3.3 RNA-Based Therapeutics and Vaccines Introduction 12.3.4 Arrowhead Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2013-2018) 12.3.5 Arrowhead Pharmaceuticals Recent Development 12.4 BioNTech 12.4.1 BioNTech Company Details 12.4.2 Company Description and Business Overview 12.4.3 RNA-Based Therapeutics and Vaccines Introduction 12.4.4 BioNTech Revenue in RNA-Based Therapeutics and Vaccines Business (2013-2018) 12.4.5 BioNTech Recent Development 12.5 CureVac 12.5.1 CureVac Company Details 12.5.2 Company Description and Business Overview 12.5.3 RNA-Based Therapeutics and Vaccines Introduction 12.5.4 CureVac Revenue in RNA-Based Therapeutics and Vaccines Business (2013-2018) 12.5.5 CureVac Recent Development 12.6 Dicerna Pharmaceuticals 12.6.1 Dicerna Pharmaceuticals Company Details 12.6.2 Company Description and Business Overview 12.6.3 RNA-Based Therapeutics and Vaccines Introduction 12.6.4 Dicerna Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2013-2018) 12.6.5 Dicerna Pharmaceuticals Recent Development 12.7 Regulus Therapeutics 12.7.1 Regulus Therapeutics Company Details 12.7.2 Company Description and Business Overview 12.7.3 RNA-Based Therapeutics and Vaccines Introduction 12.7.4 Regulus Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2013-2018) 12.7.5 Regulus Therapeutics Recent Development 12.8 Marina Biotech 12.8.1 Marina Biotech Company Details 12.8.2 Company Description and Business Overview 12.8.3 RNA-Based Therapeutics and Vaccines Introduction 12.8.4 Marina Biotech Revenue in RNA-Based Therapeutics and Vaccines Business (2013-2018) 12.8.5 Marina Biotech Recent Development 12.9 MiRagen Therapeutics 12.9.1 MiRagen Therapeutics Company Details 12.9.2 Company Description and Business Overview 12.9.3 RNA-Based Therapeutics and Vaccines Introduction 12.9.4 MiRagen Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2013-2018) 12.9.5 MiRagen Therapeutics Recent Development 12.10 Moderna Therapeutics 12.10.1 Moderna Therapeutics Company Details 12.10.2 Company Description and Business Overview 12.10.3 RNA-Based Therapeutics and Vaccines Introduction 12.10.4 Moderna Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2013-2018) 12.10.5 Moderna Therapeutics Recent Development 12.11 Quark Pharmaceuticals 12.12 Roche 12.13 Sylentis 13 Market Forecast 2018-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2018-2025) 13.10 Market Size Forecast by Application (2018-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table RNA-Based Therapeutics and Vaccines Key Market Segments Table Key Players RNA-Based Therapeutics and Vaccines Covered Table Global RNA-Based Therapeutics and Vaccines Market Size Growth Rate by Type 2013-2025 (Million US$) Figure Global RNA-Based Therapeutics and Vaccines Market Size Market Share by Type 2013-2025 Figure RNA-Based Therapeutics Figures Table Key Players of RNA-Based Therapeutics Figure RNA-Based Vaccines Figures Table Key Players of RNA-Based Vaccines Table Global RNA-Based Therapeutics and Vaccines Market Size Growth by Application 2013-2025 (Million US$) Figure Oncology Case Studies Figure Immunology Case Studies Figure Ophthalmology Case Studies Figure Cardiovascular Diseases Case Studies Figure Infectious Diseases Case Studies Figure Genetic Diseases Case Studies Figure Others Case Studies Figure RNA-Based Therapeutics and Vaccines Report Years Considered Table Global RNA-Based Therapeutics and Vaccines Market Size 2013-2025 (Million US$) Figure Global RNA-Based Therapeutics and Vaccines Market Size and Growth Rate 2013-2025 (Million US$) Table Global RNA-Based Therapeutics and Vaccines Market Size by Regions 2013-2025 (Million US$) Table Global RNA-Based Therapeutics and Vaccines Market Size by Regions 2013-2018 (Million US$) Table Global RNA-Based Therapeutics and Vaccines Market Share by Regions 2013-2018 Figure Global RNA-Based Therapeutics and Vaccines Market Share by Regions 2013-2018 Figure Global RNA-Based Therapeutics and Vaccines Market Share by Regions 2018 Table Market Top Trends Table Global RNA-Based Therapeutics and Vaccines Revenue by Manufacturers (2013-2018) (Million US$) Table Global RNA-Based Therapeutics and Vaccines Market Share by Manufacturers (2013-2018) Figure Global RNA-Based Therapeutics and Vaccines Market Share by Manufacturers in 2018 Table Global RNA-Based Therapeutics and Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players RNA-Based Therapeutics and Vaccines Product/Solution/Service Table Date of Enter into RNA-Based Therapeutics and Vaccines Market Table Mergers & Acquisitions, Expansion Plans Table Global RNA-Based Therapeutics and Vaccines Market Size by Type (2013-2018) (Million US$) Table Global RNA-Based Therapeutics and Vaccines Market Size Share by Type (2013-2018) Figure Global RNA-Based Therapeutics and Vaccines Market Size Market Share by Type (2013-2018) Table Global RNA-Based Therapeutics and Vaccines Market Size by Application (2013-2018) (Million US$) Table Global RNA-Based Therapeutics and Vaccines Market Size Share by Application (2013-2018) Figure Global RNA-Based Therapeutics and Vaccines Market Size Market Share by Application (2013-2018) Figure Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Application in 2017 Figure United States RNA-Based Therapeutics and Vaccines Market Size 2013-2018 (Million US$) Table United States Key Players RNA-Based Therapeutics and Vaccines Revenue (2017-2018) (Million US$) Table United States Key Players RNA-Based Therapeutics and Vaccines Market Share (2017-2018) Table United States RNA-Based Therapeutics and Vaccines Market Size by Type (2013-2018) (Million US$) Table United States RNA-Based Therapeutics and Vaccines Market Share by Type (2013-2018) Table United States RNA-Based Therapeutics and Vaccines Market Size by Application (2013-2018) (Million US$) Table United States RNA-Based Therapeutics and Vaccines Market Share by Application (2013-2018) Figure Europe RNA-Based Therapeutics and Vaccines Market Size 2013-2018 (Million US$) Table Europe Key Players RNA-Based Therapeutics and Vaccines Revenue (2017-2018) (Million US$) Table Europe Key Players RNA-Based Therapeutics and Vaccines Market Share (2017-2018) Table Europe RNA-Based Therapeutics and Vaccines Market Size by Type (2013-2018) (Million US$) Table Europe RNA-Based Therapeutics and Vaccines Market Share by Type (2013-2018) Table Europe RNA-Based Therapeutics and Vaccines Market Size by Application (2013-2018) (Million US$) Table Europe RNA-Based Therapeutics and Vaccines Market Share by Application (2013-2018) Figure China RNA-Based Therapeutics and Vaccines Market Size 2013-2018 (Million US$) Table China Key Players RNA-Based Therapeutics and Vaccines Revenue (2017-2018) (Million US$) Table China Key Players RNA-Based Therapeutics and Vaccines Market Share (2017-2018) Table China RNA-Based Therapeutics and Vaccines Market Size by Type (2013-2018) (Million US$) Table China RNA-Based Therapeutics and Vaccines Market Share by Type (2013-2018) Table China RNA-Based Therapeutics and Vaccines Market Size by Application (2013-2018) (Million US$) Table China RNA-Based Therapeutics and Vaccines Market Share by Application (2013-2018) Figure Japan RNA-Based Therapeutics and Vaccines Market Size 2013-2018 (Million US$) Table Japan Key Players RNA-Based Therapeutics and Vaccines Revenue (2017-2018) (Million US$) Table Japan Key Players RNA-Based Therapeutics and Vaccines Market Share (2017-2018) Table Japan RNA-Based Therapeutics and Vaccines Market Size by Type (2013-2018) (Million US$) Table Japan RNA-Based Therapeutics and Vaccines Market Share by Type (2013-2018) Table Japan RNA-Based Therapeutics and Vaccines Market Size by Application (2013-2018) (Million US$) Table Japan RNA-Based Therapeutics and Vaccines Market Share by Application (2013-2018) Figure Southeast Asia RNA-Based Therapeutics and Vaccines Market Size 2013-2018 (Million US$) Table Southeast Asia Key Players RNA-Based Therapeutics and Vaccines Revenue (2017-2018) (Million US$) Table Southeast Asia Key Players RNA-Based Therapeutics and Vaccines Market Share (2017-2018) Table Southeast Asia RNA-Based Therapeutics and Vaccines Market Size by Type (2013-2018) (Million US$) Table Southeast Asia RNA-Based Therapeutics and Vaccines Market Share by Type (2013-2018) Table Southeast Asia RNA-Based Therapeutics and Vaccines Market Size by Application (2013-2018) (Million US$) Table Southeast Asia RNA-Based Therapeutics and Vaccines Market Share by Application (2013-2018) Figure India RNA-Based Therapeutics and Vaccines Market Size 2013-2018 (Million US$) Table India Key Players RNA-Based Therapeutics and Vaccines Revenue (2017-2018) (Million US$) Table India Key Players RNA-Based Therapeutics and Vaccines Market Share (2017-2018) Table India RNA-Based Therapeutics and Vaccines Market Size by Type (2013-2018) (Million US$) Table India RNA-Based Therapeutics and Vaccines Market Share by Type (2013-2018) Table India RNA-Based Therapeutics and Vaccines Market Size by Application (2013-2018) (Million US$) Table India RNA-Based Therapeutics and Vaccines Market Share by Application (2013-2018) Figure Central & South America RNA-Based Therapeutics and Vaccines Market Size 2013-2018 (Million US$) Table Central & South America Key Players RNA-Based Therapeutics and Vaccines Revenue (2017-2018) (Million US$) Table Central & South America Key Players RNA-Based Therapeutics and Vaccines Market Share (2017-2018) Table Central & South America RNA-Based Therapeutics and Vaccines Market Size by Type (2013-2018) (Million US$) Table Central & South America RNA-Based Therapeutics and Vaccines Market Share by Type (2013-2018) Table Central & South America RNA-Based Therapeutics and Vaccines Market Size by Application (2013-2018) (Million US$) Table Central & South America RNA-Based Therapeutics and Vaccines Market Share by Application (2013-2018) Table Alnylam Pharmaceuticals Company Details Table Alnylam Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2013-2018) (Million US$) Figure Alnylam Pharmaceuticals Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2013-2018) Table Alnylam Pharmaceuticals Recent Development Table Arbutus Biopharma Company Details Table Arbutus Biopharma Revenue in RNA-Based Therapeutics and Vaccines Business (2013-2018)(Million US$) Figure Arbutus Biopharma Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2013-2018) Table Arbutus Biopharma Recent Development Table Arrowhead Pharmaceuticals Company Details Table Arrowhead Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2013-2018)(Million US$) Figure Arrowhead Pharmaceuticals Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2013-2018) Table Arrowhead Pharmaceuticals Recent Development Table BioNTech Company Details Table BioNTech Revenue in RNA-Based Therapeutics and Vaccines Business (2013-2018)(Million US$) Figure BioNTech Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2013-2018) Table BioNTech Recent Development Table CureVac Company Details Table CureVac Revenue in RNA-Based Therapeutics and Vaccines Business (2013-2018)(Million US$) Figure CureVac Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2013-2018) Table CureVac Recent Development Table Dicerna Pharmaceuticals Company Details Table Dicerna Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2013-2018)(Million US$) Figure Dicerna Pharmaceuticals Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2013-2018) Table Dicerna Pharmaceuticals Recent Development Table Regulus Therapeutics Company Details Table Regulus Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2013-2018)(Million US$) Figure Regulus Therapeutics Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2013-2018) Table Regulus Therapeutics Recent Development Table Marina Biotech Company Details Table Marina Biotech Revenue in RNA-Based Therapeutics and Vaccines Business (2013-2018)(Million US$) Figure Marina Biotech Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2013-2018) Table Marina Biotech Recent Development Table MiRagen Therapeutics Company Details Table MiRagen Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2013-2018)(Million US$) Figure MiRagen Therapeutics Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2013-2018) Table MiRagen Therapeutics Recent Development Table Moderna Therapeutics Company Details Table Moderna Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2013-2018)(Million US$) Figure Moderna Therapeutics Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2013-2018) Table Moderna Therapeutics Recent Development Table Quark Pharmaceuticals Company Details Table Roche Company Details Table Sylentis Company Details Table Global RNA-Based Therapeutics and Vaccines Market Size by Regions (Million US$) 2018-2025 Figure Global RNA-Based Therapeutics and Vaccines Market Size Share by Regions (2018-2025) Figure Global RNA-Based Therapeutics and Vaccines Market Size Share by Regions in 2025 Figure United States RNA-Based Therapeutics and Vaccines Market Size Forecast (2018-2025)(Million USD) Figure Europe RNA-Based Therapeutics and Vaccines Market Size Forecast (2018-2025)(Million USD) Figure China RNA-Based Therapeutics and Vaccines Market Size Forecast (2018-2025)(Million USD) Figure Japan RNA-Based Therapeutics and Vaccines Market Size Forecast (2018-2025)(Million USD) Figure Southeast Asia RNA-Based Therapeutics and Vaccines Market Size Forecast (2018-2025)(Million USD) Figure India RNA-Based Therapeutics and Vaccines Market Size Forecast (2018-2025)(Million USD) Figure Central & South America RNA-Based Therapeutics and Vaccines Market Size Forecast (2018-2025)(Million USD) Table Global RNA-Based Therapeutics and Vaccines Market Size by Product (2018-2025) (Million US$) Figure Global RNA-Based Therapeutics and Vaccines Market Size by Product (2018-2025) Figure Global RNA-Based Therapeutics and Vaccines Market Size by Product in 2025 Table Global RNA-Based Therapeutics and Vaccines Market Size by Application (2018-2025) (Million US$) Figure Global RNA-Based Therapeutics and Vaccines Market Size by Application (2018-2025) Figure Global RNA-Based Therapeutics and Vaccines Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources